@whytee
Statisticians at Novartis? Actually they probably are good at their jobs at Novartis. More importantly they will be well informed about how to interpret. Unlike the beancounters at Teva. What a ridiculous mess they made of that company and completely bombed with Mesoblast opportunities
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-468
-
- There are more pages in this discussion • 636 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
0.015(1.17%) |
Mkt cap ! $1.467B | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.31 | $1.27 | $1.201M | 934.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 12033 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 26938 | 5 |
View Market Depth
| Last trade - 15.05pm 05/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |